Advertisement

Ads Placeholder
Loading...

Kineta, Inc.

KANASDAQ
Healthcare
Biotechnology
$0.57
$-0.26(-30.77%)
U.S. Market opens in 55h 17m

Kineta, Inc. (KA) Stock Overview

Explore Kineta, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap7M
P/E Ratio-2.24
EPS (TTM)$-1.64
ROE0.26%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

KA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kineta, Inc. (KA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -2.24 and a market capitalization of 7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
-2.77%
1-Month Change
N/A
3-Month Change
-17.29%
6-Month Change
18.21%
Year-to-Date (YTD) Change
-83.10%
1-Year Change
-83.49%
3-Year Change
-98.76%
5-Year Change
-99.28%
All-Time (Max) Change
-99.92%

Contact Information

206 378 0400
219 Terry Ave. N, Seattle, WA, 98109

Company Facts

110 Employees
IPO DateFeb 11, 2016
CountryUS

Frequently Asked Questions